nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftazidime—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.654	1	CbGbCtD
Ceftazidime—Cardio-respiratory arrest—Aminophylline—chronic obstructive pulmonary disease	0.0121	0.0356	CcSEcCtD
Ceftazidime—Oral candidiasis—Tiotropium—chronic obstructive pulmonary disease	0.0064	0.0189	CcSEcCtD
Ceftazidime—Gastrointestinal symptom NOS—Salbutamol—chronic obstructive pulmonary disease	0.00527	0.0155	CcSEcCtD
Ceftazidime—Oral candidiasis—Arformoterol—chronic obstructive pulmonary disease	0.00516	0.0152	CcSEcCtD
Ceftazidime—Oral candidiasis—Formoterol—chronic obstructive pulmonary disease	0.00516	0.0152	CcSEcCtD
Ceftazidime—Dermatitis atopic—Montelukast—chronic obstructive pulmonary disease	0.00434	0.0128	CcSEcCtD
Ceftazidime—Skin exfoliation—Aminophylline—chronic obstructive pulmonary disease	0.00411	0.0121	CcSEcCtD
Ceftazidime—Injection site pain—Arformoterol—chronic obstructive pulmonary disease	0.00402	0.0118	CcSEcCtD
Ceftazidime—Injection site pain—Formoterol—chronic obstructive pulmonary disease	0.00402	0.0118	CcSEcCtD
Ceftazidime—Coma—Aminophylline—chronic obstructive pulmonary disease	0.00394	0.0116	CcSEcCtD
Ceftazidime—Candida infection—Tiotropium—chronic obstructive pulmonary disease	0.00388	0.0114	CcSEcCtD
Ceftazidime—Phlebitis—Aminophylline—chronic obstructive pulmonary disease	0.00363	0.0107	CcSEcCtD
Ceftazidime—Infestation NOS—Roflumilast—chronic obstructive pulmonary disease	0.00361	0.0107	CcSEcCtD
Ceftazidime—Infestation—Roflumilast—chronic obstructive pulmonary disease	0.00361	0.0107	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00342	0.0101	CcSEcCtD
Ceftazidime—Inflammation—Formoterol—chronic obstructive pulmonary disease	0.00338	0.00997	CcSEcCtD
Ceftazidime—Inflammation—Arformoterol—chronic obstructive pulmonary disease	0.00338	0.00997	CcSEcCtD
Ceftazidime—Inflammation—Salbutamol—chronic obstructive pulmonary disease	0.00319	0.00942	CcSEcCtD
Ceftazidime—Candida infection—Arformoterol—chronic obstructive pulmonary disease	0.00313	0.00924	CcSEcCtD
Ceftazidime—Candida infection—Formoterol—chronic obstructive pulmonary disease	0.00313	0.00924	CcSEcCtD
Ceftazidime—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00293	0.00865	CcSEcCtD
Ceftazidime—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00277	0.00816	CcSEcCtD
Ceftazidime—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00265	0.00781	CcSEcCtD
Ceftazidime—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00258	0.00761	CcSEcCtD
Ceftazidime—Cefdinir—MPO—chronic obstructive pulmonary disease	0.00246	0.373	CrCbGaD
Ceftazidime—Cefaclor—MPO—chronic obstructive pulmonary disease	0.00244	0.37	CrCbGaD
Ceftazidime—Dermatitis atopic—Prednisolone—chronic obstructive pulmonary disease	0.0024	0.00708	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00239	0.00705	CcSEcCtD
Ceftazidime—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00226	0.00667	CcSEcCtD
Ceftazidime—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00224	0.00661	CcSEcCtD
Ceftazidime—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.00223	0.00659	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.0021	0.00619	CcSEcCtD
Ceftazidime—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.00202	0.00597	CcSEcCtD
Ceftazidime—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.00202	0.00597	CcSEcCtD
Ceftazidime—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00201	0.00592	CcSEcCtD
Ceftazidime—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.002	0.00589	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00199	0.00587	CcSEcCtD
Ceftazidime—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00191	0.00564	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00189	0.00556	CcSEcCtD
Ceftazidime—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00185	0.00546	CcSEcCtD
Ceftazidime—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00184	0.00544	CcSEcCtD
Ceftazidime—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00183	0.0054	CcSEcCtD
Ceftazidime—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00182	0.00538	CcSEcCtD
Ceftazidime—Infestation—Montelukast—chronic obstructive pulmonary disease	0.0018	0.0053	CcSEcCtD
Ceftazidime—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.0018	0.0053	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00178	0.00526	CcSEcCtD
Ceftazidime—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00176	0.00521	CcSEcCtD
Ceftazidime—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00175	0.00517	CcSEcCtD
Ceftazidime—Dermatitis atopic—Prednisone—chronic obstructive pulmonary disease	0.00174	0.00514	CcSEcCtD
Ceftazidime—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00173	0.00511	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.0017	0.00501	CcSEcCtD
Ceftazidime—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.0017	0.00501	CcSEcCtD
Ceftazidime—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00169	0.00498	CcSEcCtD
Ceftazidime—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00167	0.00494	CcSEcCtD
Ceftazidime—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00163	0.00481	CcSEcCtD
Ceftazidime—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00162	0.00479	CcSEcCtD
Ceftazidime—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.0016	0.00473	CcSEcCtD
Ceftazidime—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00158	0.00465	CcSEcCtD
Ceftazidime—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00461	CcSEcCtD
Ceftazidime—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00459	CcSEcCtD
Ceftazidime—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00154	0.00454	CcSEcCtD
Ceftazidime—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00153	0.0045	CcSEcCtD
Ceftazidime—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00152	0.0045	CcSEcCtD
Ceftazidime—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00151	0.00445	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.0015	0.00443	CcSEcCtD
Ceftazidime—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.00149	0.00439	CcSEcCtD
Ceftazidime—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00149	0.00439	CcSEcCtD
Ceftazidime—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.00439	CcSEcCtD
Ceftazidime—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00147	0.00432	CcSEcCtD
Ceftazidime—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00146	0.0043	CcSEcCtD
Ceftazidime—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00145	0.00429	CcSEcCtD
Ceftazidime—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00145	0.00428	CcSEcCtD
Ceftazidime—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00144	0.00426	CcSEcCtD
Ceftazidime—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.00426	CcSEcCtD
Ceftazidime—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00144	0.00424	CcSEcCtD
Ceftazidime—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00142	0.00419	CcSEcCtD
Ceftazidime—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00416	CcSEcCtD
Ceftazidime—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00141	0.00415	CcSEcCtD
Ceftazidime—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.00414	CcSEcCtD
Ceftazidime—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00414	CcSEcCtD
Ceftazidime—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00414	CcSEcCtD
Ceftazidime—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00137	0.00404	CcSEcCtD
Ceftazidime—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00396	CcSEcCtD
Ceftazidime—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00396	CcSEcCtD
Ceftazidime—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00391	CcSEcCtD
Ceftazidime—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00389	CcSEcCtD
Ceftazidime—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00389	CcSEcCtD
Ceftazidime—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00388	CcSEcCtD
Ceftazidime—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00386	CcSEcCtD
Ceftazidime—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00386	CcSEcCtD
Ceftazidime—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.0013	0.00384	CcSEcCtD
Ceftazidime—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00381	CcSEcCtD
Ceftazidime—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00379	CcSEcCtD
Ceftazidime—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00374	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00371	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00369	CcSEcCtD
Ceftazidime—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00367	CcSEcCtD
Ceftazidime—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00365	CcSEcCtD
Ceftazidime—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.00123	0.00363	CcSEcCtD
Ceftazidime—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.0036	CcSEcCtD
Ceftazidime—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00359	CcSEcCtD
Ceftazidime—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.00359	CcSEcCtD
Ceftazidime—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.00359	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00358	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00358	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00119	0.0035	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.0035	CcSEcCtD
Ceftazidime—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00345	CcSEcCtD
Ceftazidime—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00345	CcSEcCtD
Ceftazidime—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.0034	CcSEcCtD
Ceftazidime—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00338	CcSEcCtD
Ceftazidime—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00338	CcSEcCtD
Ceftazidime—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00338	CcSEcCtD
Ceftazidime—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00115	0.00338	CcSEcCtD
Ceftazidime—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00335	CcSEcCtD
Ceftazidime—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00335	CcSEcCtD
Ceftazidime—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.00334	CcSEcCtD
Ceftazidime—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00332	CcSEcCtD
Ceftazidime—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00331	CcSEcCtD
Ceftazidime—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00328	CcSEcCtD
Ceftazidime—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00326	CcSEcCtD
Ceftazidime—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00323	CcSEcCtD
Ceftazidime—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00323	CcSEcCtD
Ceftazidime—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00321	CcSEcCtD
Ceftazidime—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.0032	CcSEcCtD
Ceftazidime—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00319	CcSEcCtD
Ceftazidime—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00317	CcSEcCtD
Ceftazidime—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00315	CcSEcCtD
Ceftazidime—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.0031	CcSEcCtD
Ceftazidime—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00305	CcSEcCtD
Ceftazidime—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00304	CcSEcCtD
Ceftazidime—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00303	CcSEcCtD
Ceftazidime—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00102	0.003	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00298	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00298	CcSEcCtD
Ceftazidime—Pain—Arformoterol—chronic obstructive pulmonary disease	0.001	0.00295	CcSEcCtD
Ceftazidime—Pain—Formoterol—chronic obstructive pulmonary disease	0.001	0.00295	CcSEcCtD
Ceftazidime—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000992	0.00293	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000989	0.00292	CcSEcCtD
Ceftazidime—Pain—Montelukast—chronic obstructive pulmonary disease	0.00098	0.00289	CcSEcCtD
Ceftazidime—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000977	0.00288	CcSEcCtD
Ceftazidime—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000969	0.00286	CcSEcCtD
Ceftazidime—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000968	0.00286	CcSEcCtD
Ceftazidime—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000963	0.00284	CcSEcCtD
Ceftazidime—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000959	0.00283	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000957	0.00282	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000957	0.00282	CcSEcCtD
Ceftazidime—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000956	0.00282	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000954	0.00281	CcSEcCtD
Ceftazidime—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000945	0.00279	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000937	0.00276	CcSEcCtD
Ceftazidime—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000929	0.00274	CcSEcCtD
Ceftazidime—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000929	0.00274	CcSEcCtD
Ceftazidime—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000925	0.00273	CcSEcCtD
Ceftazidime—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000925	0.00273	CcSEcCtD
Ceftazidime—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000925	0.00273	CcSEcCtD
Ceftazidime—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000925	0.00273	CcSEcCtD
Ceftazidime—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000922	0.00272	CcSEcCtD
Ceftazidime—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000914	0.0027	CcSEcCtD
Ceftazidime—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000913	0.00269	CcSEcCtD
Ceftazidime—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000913	0.00269	CcSEcCtD
Ceftazidime—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00091	0.00269	CcSEcCtD
Ceftazidime—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000908	0.00268	CcSEcCtD
Ceftazidime—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000906	0.00267	CcSEcCtD
Ceftazidime—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000906	0.00267	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000903	0.00267	CcSEcCtD
Ceftazidime—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000896	0.00264	CcSEcCtD
Ceftazidime—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000892	0.00263	CcSEcCtD
Ceftazidime—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000878	0.00259	CcSEcCtD
Ceftazidime—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000873	0.00258	CcSEcCtD
Ceftazidime—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000873	0.00258	CcSEcCtD
Ceftazidime—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000862	0.00254	CcSEcCtD
Ceftazidime—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000862	0.00254	CcSEcCtD
Ceftazidime—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000861	0.00254	CcSEcCtD
Ceftazidime—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000844	0.00249	CcSEcCtD
Ceftazidime—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000828	0.00244	CcSEcCtD
Ceftazidime—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000828	0.00244	CcSEcCtD
Ceftazidime—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000814	0.0024	CcSEcCtD
Ceftazidime—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000811	0.00239	CcSEcCtD
Ceftazidime—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000801	0.00236	CcSEcCtD
Ceftazidime—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000801	0.00236	CcSEcCtD
Ceftazidime—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000784	0.00231	CcSEcCtD
Ceftazidime—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000782	0.00231	CcSEcCtD
Ceftazidime—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000774	0.00228	CcSEcCtD
Ceftazidime—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000774	0.00228	CcSEcCtD
Ceftazidime—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000758	0.00224	CcSEcCtD
Ceftazidime—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000757	0.00223	CcSEcCtD
Ceftazidime—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000756	0.00223	CcSEcCtD
Ceftazidime—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000744	0.00219	CcSEcCtD
Ceftazidime—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000744	0.00219	CcSEcCtD
Ceftazidime—Rash—Formoterol—chronic obstructive pulmonary disease	0.000738	0.00218	CcSEcCtD
Ceftazidime—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000738	0.00218	CcSEcCtD
Ceftazidime—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000737	0.00217	CcSEcCtD
Ceftazidime—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000737	0.00217	CcSEcCtD
Ceftazidime—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000733	0.00216	CcSEcCtD
Ceftazidime—Headache—Formoterol—chronic obstructive pulmonary disease	0.000733	0.00216	CcSEcCtD
Ceftazidime—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000732	0.00216	CcSEcCtD
Ceftazidime—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000731	0.00216	CcSEcCtD
Ceftazidime—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000729	0.00215	CcSEcCtD
Ceftazidime—Rash—Montelukast—chronic obstructive pulmonary disease	0.000723	0.00213	CcSEcCtD
Ceftazidime—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000722	0.00213	CcSEcCtD
Ceftazidime—Headache—Montelukast—chronic obstructive pulmonary disease	0.000718	0.00212	CcSEcCtD
Ceftazidime—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000709	0.00209	CcSEcCtD
Ceftazidime—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000702	0.00207	CcSEcCtD
Ceftazidime—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000697	0.00205	CcSEcCtD
Ceftazidime—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000696	0.00205	CcSEcCtD
Ceftazidime—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000695	0.00205	CcSEcCtD
Ceftazidime—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000695	0.00205	CcSEcCtD
Ceftazidime—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000692	0.00204	CcSEcCtD
Ceftazidime—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000681	0.00201	CcSEcCtD
Ceftazidime—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000673	0.00198	CcSEcCtD
Ceftazidime—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000656	0.00194	CcSEcCtD
Ceftazidime—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000651	0.00192	CcSEcCtD
Ceftazidime—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000648	0.00191	CcSEcCtD
Ceftazidime—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000645	0.0019	CcSEcCtD
Ceftazidime—Ceftriaxone—ALB—chronic obstructive pulmonary disease	0.000634	0.0962	CrCbGaD
Ceftazidime—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000634	0.00187	CcSEcCtD
Ceftazidime—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000601	0.00177	CcSEcCtD
Ceftazidime—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000588	0.00173	CcSEcCtD
Ceftazidime—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000585	0.00173	CcSEcCtD
Ceftazidime—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000569	0.00168	CcSEcCtD
Ceftazidime—Cefalotin—ALB—chronic obstructive pulmonary disease	0.000555	0.0843	CrCbGaD
Ceftazidime—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000542	0.0016	CcSEcCtD
Ceftazidime—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000532	0.00157	CcSEcCtD
Ceftazidime—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000518	0.00153	CcSEcCtD
Ceftazidime—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000516	0.00152	CcSEcCtD
Ceftazidime—Cephalexin—ALB—chronic obstructive pulmonary disease	0.000505	0.0766	CrCbGaD
Ceftazidime—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000503	0.00149	CcSEcCtD
Ceftazidime—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000489	0.00144	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000477	0.00141	CcSEcCtD
Ceftazidime—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000467	0.00138	CcSEcCtD
Ceftazidime—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00046	0.00136	CcSEcCtD
Ceftazidime—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000452	0.00133	CcSEcCtD
Ceftazidime—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000447	0.00132	CcSEcCtD
Ceftazidime—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000419	0.00124	CcSEcCtD
Ceftazidime—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000413	0.00122	CcSEcCtD
Ceftazidime—Rash—Prednisolone—chronic obstructive pulmonary disease	0.0004	0.00118	CcSEcCtD
Ceftazidime—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000399	0.00118	CcSEcCtD
Ceftazidime—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000397	0.00117	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000377	0.00111	CcSEcCtD
Ceftazidime—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000376	0.00111	CcSEcCtD
Ceftazidime—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000366	0.00108	CcSEcCtD
Ceftazidime—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000364	0.00107	CcSEcCtD
Ceftazidime—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000364	0.00107	CcSEcCtD
Ceftazidime—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000339	0.001	CcSEcCtD
Ceftazidime—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000326	0.000961	CcSEcCtD
Ceftazidime—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000315	0.000929	CcSEcCtD
Ceftazidime—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000304	0.000898	CcSEcCtD
Ceftazidime—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000293	0.000864	CcSEcCtD
Ceftazidime—Rash—Prednisone—chronic obstructive pulmonary disease	0.00029	0.000856	CcSEcCtD
Ceftazidime—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00029	0.000856	CcSEcCtD
Ceftazidime—Headache—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000851	CcSEcCtD
Ceftazidime—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000807	CcSEcCtD
